drugset / Trial / NCT02555150
A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this randomized, double-blind, crossover study is to compare two long-acting stimulant formulations-once-daily PRC-063 and once-daily lisdexamfetamine (LDX)-through a 15-hour period on driving performance, as measured with a driving simulator, in adult patients with ADHD.
Timeline
- Start
- 2015-09
- Primary completion
- 2017-01
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lisdexamfetamine | Other / unclassified | 30 mg | Oral |
| Comparator | Lisdexamfetamine | Other / unclassified | 50 mg | Oral |
| Comparator | Lisdexamfetamine | Other / unclassified | 70 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 45 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 70 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 100 mg | Oral |